Clinical Trial Update: A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tacrolimus (Prograf) and cyclosporine (Neoral) in kidney transplant recipients; the study was terminated and results were posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• NEORAL (CYCLOSPORINE)
• Prograf (Tacrolimus)

Snippet

Sponsor: Loma Linda University | Conditions: Renal Transplant Rejection | Phase 4 | Status: TERMINATED | Results posted: 2015-10-20